These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18166168)

  • 1. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
    Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
    Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
    J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
    Park JE; Lee ST; Im WS; Chu K; Kim M
    Neurosci Lett; 2008 Dec; 448(1):143-7. PubMed ID: 18938211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
    Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
    Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
    Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid.
    Dautry C; Vaufrey F; Brouillet E; Bizat N; Henry PG; Condé F; Bloch G; Hantraye P
    J Cereb Blood Flow Metab; 2000 May; 20(5):789-99. PubMed ID: 10826529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.
    Puerta E; Hervias I; Barros-Miñones L; Jordan J; Ricobaraza A; Cuadrado-Tejedor M; García-Osta A; Aguirre N
    Neurobiol Dis; 2010 May; 38(2):237-45. PubMed ID: 20109548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid.
    Kraft JC; Osterhaus GL; Ortiz AN; Garris PA; Johnson MA
    Neuroscience; 2009 Jul; 161(3):940-9. PubMed ID: 19362126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
    Rossignol J; Boyer C; Lévèque X; Fink KD; Thinard R; Blanchard F; Dunbar GL; Lescaudron L
    Behav Brain Res; 2011 Mar; 217(2):369-78. PubMed ID: 21070819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.
    El Massioui N; Ouary S; Chéruel F; Hantraye P; Brouillet E
    Exp Neurol; 2001 Nov; 172(1):172-81. PubMed ID: 11681849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A; Akula KK; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
    Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats.
    Tsai RK; Chang CH; Wang HZ
    Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
    Duan W; Guo Z; Mattson MP
    Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
    Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecally injected granulocyte colony-stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt pathways.
    Chen WF; Jean YH; Sung CS; Wu GJ; Huang SY; Ho JT; Su TM; Wen ZH
    Neuroscience; 2008 Apr; 153(1):31-43. PubMed ID: 18358629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
    Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
    J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.